Multimodal Approach to the Intrathecal Catheter for Obstetric Accidental Dural Puncture
NCT ID: NCT05910086
Last Updated: 2023-06-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
39 participants
OBSERVATIONAL
2022-03-01
2023-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post-dural Puncture Headache: A Retrospective Study
NCT03790124
Chronic Headache and Chronic Backache Following Unintentional Dural Puncture at Delivery Room.
NCT03908424
Alteration in Hearing Following Accidental Dural Puncture. A Study in Parturients
NCT01682967
The Occurrence of Post Dural Puncture Headache After Epidural Blood Patch
NCT03080610
Incidence of Headache Following an Unintentional Dural Puncture
NCT01977898
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients having an accidental dural puncture during the installation of an epidural anesthesia
patients having an accidental dural puncture during the installation of an epidural anesthesia will be included.
Analysis datas of medical record.
collection of data from the medical record
collection of data from the medical record:
1. During epidural space puncture = cerebrospinal fluid (CSF) reflux, presence of glucose / strip, saline injection, intrathecal catheter insertion, intrathecal levobupivacaine and sufentanil injection, catheter insertion time, number of punctures, function of the person performing the procedure.
2. Analgesia and hemodynamics during labor, blood pressure, pulse rate, amount of local anesthetic used, whether emergency cesarean section was performed
3. Demographic data (age, weight, height, body mass index (BMI))
4. Post-partum monitoring of decubitus or orthostatic headaches, intensity, any other associated clinical signs
5. Analgesics used and their efficacy
6. The use of one or more blood patches, with the volume injected and their efficacy
7. Identification of the breach during epidural analgesia or after delivery
8. Call the patient at 1 week to reassess the episode and its consequences.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
collection of data from the medical record
collection of data from the medical record:
1. During epidural space puncture = cerebrospinal fluid (CSF) reflux, presence of glucose / strip, saline injection, intrathecal catheter insertion, intrathecal levobupivacaine and sufentanil injection, catheter insertion time, number of punctures, function of the person performing the procedure.
2. Analgesia and hemodynamics during labor, blood pressure, pulse rate, amount of local anesthetic used, whether emergency cesarean section was performed
3. Demographic data (age, weight, height, body mass index (BMI))
4. Post-partum monitoring of decubitus or orthostatic headaches, intensity, any other associated clinical signs
5. Analgesics used and their efficacy
6. The use of one or more blood patches, with the volume injected and their efficacy
7. Identification of the breach during epidural analgesia or after delivery
8. Call the patient at 1 week to reassess the episode and its consequences.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pascal MARTIN, MD
Role: PRINCIPAL_INVESTIGATOR
CHU SAINT-ETIENNE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Saint-Etienne
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRBN632022/CHUSTE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.